In vivo studies in animal models of type 1 diabetes have established that C-peptide administration results in significant improvements in nerve and kidney function.
Os estudos in vivo en modelos animais da diabetes tipo 1 estbleceron que a administración do péptido C causa melloras significativas na función dos riles e nervios.